Reza Zadno - 09 May 2025 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Reporting relationship: President, CEO, Director
Issuer ticker: PRCT
Reported as of: 09 May 2025
Net transaction value: +$100,028
SEC form: 4
Accepted by SEC: 13 May 2025, 16:59:33 UTC
Prior SEC filing: 19 Mar 2025
Next SEC filing: 16 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Jonathan Stone, Attorney-in-Fact for Reza Zadno, Ph.D.

Key filing fact

Reza Zadno filed Form 4 for PROCEPT BioRobotics Corp (PRCT) on 13 May 2025.

Key facts

This page summarizes Reza Zadno's Form 4 filing for PROCEPT BioRobotics Corp (PRCT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 13 May 2025, 16:59.

Change

Previous filing in this sequence was filed on 19 Mar 2025.
Current net transaction value: +$100,028.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001632326 Primary reporting owner

Zadno Reza

Relationship: President, CEO, Director
Address: C/O PROCEPT BIOROBOTICS CORPORATION, 150 BAYTECH DRIVE, SAN JOSE
Signature: /s/ Jonathan Stone, Attorney-in-Fact for Reza Zadno, Ph.D.
Signature date: 13 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PRCT transaction

Common Stock

Options Exercise

Transaction value: $100,028
Shares: +13,759
Change %: +7.9%
Price: $7.27
Shares after: 186,829
Date: 09 May 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PRCT transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -13,759
Change %: -8%
Price: $0.000000
Shares after: 158,871
Date: 09 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 13,759
Exercise price: $7.27
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Stock option was granted on June 22, 2021 and vests 25% on the six month anniversary of the grant date and the remainder vests on each monthly anniversary over a four year period thereafter, subject continued employment or service to the Issuer through the applicable vesting date.